ID   SOX4_HUMAN              Reviewed;         474 AA.
AC   Q06945;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   07-APR-2021, entry version 171.
DE   RecName: Full=Transcription factor SOX-4;
GN   Name=SOX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8268656; DOI=10.1007/bf00361388;
RA   Farr C.J., Easty D.J., Ragoussis J., Collignon J., Lovell-Badge R.,
RA   Goodfellow P.N.;
RT   "Characterization and mapping of the human SOX4 gene.";
RL   Mamm. Genome 4:577-584(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 70-123.
RX   PubMed=1614875; DOI=10.1093/nar/20.11.2887;
RA   Denny P., Swift S., Brand N., Dabhade N., Barton P., Ashworth A.;
RT   "A conserved family of genes related to the testis determining gene, SRY.";
RL   Nucleic Acids Res. 20:2887-2887(1992).
RN   [5]
RP   INTERACTION WITH UBE2I, AND SUBCELLULAR LOCATION.
RX   PubMed=16631117; DOI=10.1016/j.bbrc.2006.03.194;
RA   Pan X., Li H., Zhang P., Jin B., Man J., Tian L., Su G., Zhao J., Li W.,
RA   Liu H., Gong W., Zhou T., Zhang X.;
RT   "Ubc9 interacts with SOX4 and represses its transcriptional activity.";
RL   Biochem. Biophys. Res. Commun. 344:727-734(2006).
RN   [6]
RP   INVOLVEMENT IN CSS10, VARIANTS CSS10 SER-59; LEU-66; ASN-105 AND PRO-112,
RP   CHARACTERIZATION OF VARIANTS CSS10 SER-59; LEU-66; ASN-105 AND PRO-112, AND
RP   FUNCTION.
RX   PubMed=30661772; DOI=10.1016/j.ajhg.2018.12.014;
RG   Deciphering Developmental Disorders Study;
RG   University of Washington Center for Mendelian Genomics;
RA   Zawerton A., Yao B., Yeager J.P., Pippucci T., Haseeb A., Smith J.D.,
RA   Wischmann L., Kuehl S.J., Dean J.C.S., Pilz D.T., Holder S.E., McNeill A.,
RA   Graziano C., Lefebvre V.;
RT   "De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with
RT   Mild Dysmorphism.";
RL   Am. J. Hum. Genet. 104:246-259(2019).
CC   -!- FUNCTION: Transcriptional activator that binds with high affinity to
CC       the T-cell enhancer motif 5'-AACAAAG-3' motif (PubMed:30661772).
CC       Required for IL17A-producing Vgamma2-positive gamma-delta T-cell
CC       maturation and development, via binding to regulator loci of RORC to
CC       modulate expression (By similarity). {ECO:0000250|UniProtKB:Q06831,
CC       ECO:0000269|PubMed:30661772}.
CC   -!- SUBUNIT: Interacts with UBE2I. {ECO:0000269|PubMed:16631117}.
CC   -!- INTERACTION:
CC       Q06945; P04637: TP53; NbExp=4; IntAct=EBI-6672525, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267,
CC       ECO:0000269|PubMed:16631117}.
CC   -!- TISSUE SPECIFICITY: Testis, brain, and heart.
CC   -!- DISEASE: Coffin-Siris syndrome 10 (CSS10) [MIM:618506]: A form of
CC       Coffin-Siris syndrome, a congenital multiple malformation syndrome with
CC       broad phenotypic and genetic variability. Cardinal features are
CC       intellectual disability, coarse facial features, hypertrichosis, and
CC       hypoplastic or absent fifth digit nails or phalanges. Additional
CC       features include malformations of the cardiac, gastrointestinal,
CC       genitourinary, and/or central nervous systems. Sucking/feeding
CC       difficulties, poor growth, ophthalmologic abnormalities, hearing
CC       impairment, and spinal anomalies are common findings. CSS10 is
CC       characterized by mild to severe intellectual disability, global
CC       developmental delay, mild but distinct facial dysmorphism, fifth finger
CC       clinodactyly, and small stature. Hypotonia, ventricular septal defect,
CC       and spastic quadriparesis may also be present. CSS10 inheritance is
CC       autosomal dominant. {ECO:0000269|PubMed:30661772}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SOX4ID42358ch6p22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X70683; CAA50018.1; -; mRNA.
DR   EMBL; AL136179; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC072668; AAH72668.1; -; mRNA.
DR   EMBL; X65661; CAA46612.1; -; mRNA.
DR   CCDS; CCDS4547.1; -.
DR   PIR; I38240; I38240.
DR   RefSeq; NP_003098.1; NM_003107.2.
DR   SMR; Q06945; -.
DR   BioGRID; 112542; 49.
DR   CORUM; Q06945; -.
DR   DIP; DIP-58650N; -.
DR   IntAct; Q06945; 4.
DR   STRING; 9606.ENSP00000244745; -.
DR   iPTMnet; Q06945; -.
DR   PhosphoSitePlus; Q06945; -.
DR   BioMuta; SOX4; -.
DR   DMDM; 548952; -.
DR   EPD; Q06945; -.
DR   MassIVE; Q06945; -.
DR   MaxQB; Q06945; -.
DR   PaxDb; Q06945; -.
DR   PeptideAtlas; Q06945; -.
DR   PRIDE; Q06945; -.
DR   ProteomicsDB; 58488; -.
DR   Antibodypedia; 25243; 286 antibodies.
DR   DNASU; 6659; -.
DR   Ensembl; ENST00000244745; ENSP00000244745; ENSG00000124766.
DR   GeneID; 6659; -.
DR   KEGG; hsa:6659; -.
DR   UCSC; uc003ndi.4; human.
DR   CTD; 6659; -.
DR   DisGeNET; 6659; -.
DR   GeneCards; SOX4; -.
DR   HGNC; HGNC:11200; SOX4.
DR   HPA; ENSG00000124766; Tissue enhanced (blood).
DR   MalaCards; SOX4; -.
DR   MIM; 184430; gene.
DR   MIM; 618506; phenotype.
DR   neXtProt; NX_Q06945; -.
DR   OpenTargets; ENSG00000124766; -.
DR   Orphanet; 1465; Coffin-Siris syndrome.
DR   PharmGKB; PA36037; -.
DR   VEuPathDB; HostDB:ENSG00000124766.5; -.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000161470; -.
DR   HOGENOM; CLU_043342_0_0_1; -.
DR   InParanoid; Q06945; -.
DR   OMA; HRSYTSL; -.
DR   OrthoDB; 1186233at2759; -.
DR   PhylomeDB; Q06945; -.
DR   PathwayCommons; Q06945; -.
DR   Reactome; R-HSA-3769402; Deactivation of the beta-catenin transactivating complex.
DR   SIGNOR; Q06945; -.
DR   BioGRID-ORCS; 6659; 31 hits in 1020 CRISPR screens.
DR   ChiTaRS; SOX4; human.
DR   GeneWiki; SOX4; -.
DR   GenomeRNAi; 6659; -.
DR   Pharos; Q06945; Tbio.
DR   PRO; PR:Q06945; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q06945; protein.
DR   Bgee; ENSG00000124766; Expressed in cerebral cortex and 245 other tissues.
DR   Genevisible; Q06945; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; IEA:Ensembl.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0035198; F:miRNA binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0035910; P:ascending aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003289; P:atrial septum primum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003211; P:cardiac ventricle formation; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; IDA:UniProtKB.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0021782; P:glial cell development; ISS:UniProtKB.
DR   GO; GO:0014009; P:glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISS:BHF-UCL.
DR   GO; GO:0061484; P:hematopoietic stem cell homeostasis; IEA:Ensembl.
DR   GO; GO:0060993; P:kidney morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060174; P:limb bud formation; ISS:UniProtKB.
DR   GO; GO:0003183; P:mitral valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0001841; P:neural tube formation; ISS:UniProtKB.
DR   GO; GO:0060563; P:neuroepithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0003357; P:noradrenergic neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:BHF-UCL.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:2000761; P:positive regulation of N-terminal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:UniProtKB.
DR   GO; GO:0002328; P:pro-B cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0001501; P:skeletal system development; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; ISS:UniProtKB.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
DR   Gene3D; 1.10.30.10; -; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR017386; SOX-12/11/4.
DR   Pfam; PF00505; HMG_box; 1.
DR   PIRSF; PIRSF038098; SOX-12/11/4a; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Disease variant; DNA-binding; Mental retardation; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..474
FT                   /note="Transcription factor SOX-4"
FT                   /id="PRO_0000048724"
FT   DNA_BIND        59..127
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   COMPBIAS        386..397
FT                   /note="Poly-Ser"
FT   VARIANT         59
FT                   /note="I -> S (in CSS10; loss of DNA-binding transcription
FT                   factor activity)"
FT                   /evidence="ECO:0000269|PubMed:30661772"
FT                   /id="VAR_083360"
FT   VARIANT         66
FT                   /note="F -> L (in CSS10; loss of DNA-binding transcription
FT                   factor activity; dbSNP:rs1334099693)"
FT                   /evidence="ECO:0000269|PubMed:30661772"
FT                   /id="VAR_083361"
FT   VARIANT         105
FT                   /note="K -> N (in CSS10; loss of DNA-binding transcription
FT                   factor activity)"
FT                   /evidence="ECO:0000269|PubMed:30661772"
FT                   /id="VAR_083362"
FT   VARIANT         112
FT                   /note="A -> P (in CSS10; loss DNA-binding transcription
FT                   factor activity)"
FT                   /evidence="ECO:0000269|PubMed:30661772"
FT                   /id="VAR_083363"
FT   CONFLICT        71
FT                   /note="Q -> P (in Ref. 4; CAA46612)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   474 AA;  47263 MW;  CB75B76ABF507A07 CRC64;
     MVQQTNNAEN TEALLAGESS DSGAGLELGI ASSPTPGSTA STGGKADDPS WCKTPSGHIK
     RPMNAFMVWS QIERRKIMEQ SPDMHNAEIS KRLGKRWKLL KDSDKIPFIR EAERLRLKHM
     ADYPDYKYRP RKKVKSGNAN SSSSAAASSK PGEKGDKVGG SGGGGHGGGG GGGSSNAGGG
     GGGASGGGAN SKPAQKKSCG SKVAGGAGGG VSKPHAKLIL AGGGGGGKAA AAAAASFAAE
     QAGAAALLPL GAAADHHSLY KARTPSASAS ASSAASASAA LAAPGKHLAE KKVKRVYLFG
     GLGTSSSPVG GVGAGADPSD PLGLYEEEGA GCSPDAPSLS GRSSAASSPA AGRSPADHRG
     YASLRAASPA PSSAPSHASS SASSHSSSSS SSGSSSSDDE FEDDLLDLNP SSNFESMSLG
     SFSSSSALDR DLDFNFEPGS GSHFEFPDYC TPEVSEMISG DWLESSISNL VFTY
//
